GOURLAY STEVE

PrivateCIK: 1751884
Location

SOUTH SAN FRANCISCO, CA

GOURLAY STEVE enters PRINCIPIA BIOPHARMA INC. with 100.59K shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Derivatives
InsiderGOURLAY STEVECIK 1751884
IssuerPRINCIPIA BIOPHARMA INC.CIK 1510487
Officer· Chief Medical Officer
Since Sep 2018
100.59K
Baseline shares
100% direct
100.59K
Direct ownership
1 position
110.13K
Derivative underlying
7 instruments
1
Security positions
All direct
Non-Derivative Holdings1

Common Stock

Direct
Shares owned100.59K
Total
100.59K direct100.59K
Derivative Holdings7

Employee Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

5.14K

Shares owned

N/A

Exercise price

4.9961

Expiration

Exercise window

Employee Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

10.24K

Shares owned

N/A

Exercise price

9.0839

Expiration

Exercise window

Employee Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

44.03K

Shares owned

N/A

Exercise price

11.3549

Expiration

Exercise window

Warrant to Purchase Series B-3 Preferred Stock

Direct
Underlying security
Series B-3 Preferred Stock

Underlying shares

625.00

Shares owned

N/A

Exercise price

8.9931

Expiration

Exercise window

Employee Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

20.04K

Shares owned

N/A

Exercise price

4.7236

Expiration

Exercise window

Series B-3 Preferred Stock

Direct
Underlying security
Common Stock

Underlying shares

7.27K

Shares owned

N/A

Exercise price

0.00

Expiration

Exercise window

Employee Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

22.79K

Shares owned

N/A

Exercise price

7.2671

Expiration

Exercise window

Total

Underlying

110.13K

Owned

0.00

GOURLAY STEVE — Initial Ownership Disclosure (Form 3) Filed Sep 13, 2018 | Finecho